Saban Elitok Selected Research

Biomarkers (Surrogate Marker)

3/2022	NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery: a prospective observational study.
1/2012	Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saban Elitok Research Topics

Disease

8	Acute Kidney Injury (Acute Renal Failure) 09/2022 - 08/2011
4	Chronic Renal Insufficiency 01/2021 - 08/2016
2	Inflammation (Inflammations) 09/2022 - 09/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	acquired Thrombotic thrombocytopenic purpura 01/2020 - 01/2020
2	Hypertension (High Blood Pressure) 10/2015 - 06/2009
1	Ischemia 09/2022
1	Infections 07/2022
1	Kidney Diseases (Kidney Disease) 03/2022
1	Vascular Calcification 09/2021
1	Rheumatoid Arthritis 06/2020
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 06/2020
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2020
1	Disease Progression 01/2020
1	Acute Disease 01/2020
1	Vitamin D Deficiency 01/2019
1	Bone Diseases (Bone Disease) 01/2019
1	Heart Failure 01/2019
1	Stroke (Strokes) 01/2019
1	Acute Coronary Syndrome 01/2019
1	Feeding and Eating Disorders (Eating Disorder) 08/2016
1	Brachydactyly with hypertension 10/2015
1	Thromboangiitis Obliterans (Buerger's Disease) 09/2014
1	Immune System Diseases (Immune Disorders) 04/2013
1	Renal Insufficiency (Renal Failure) 08/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2011
1	Atherosclerosis 01/2006
1	Sclerosis 09/2004
1	Proteinuria 09/2004
1	Body Weight (Weight, Body) 09/2004
1	Cicatrix (Scar) 09/2004
1	Hyperglycemia 09/2004

Drug/Important Bio-Agent (IBA)

5	CreatinineIBA 07/2021 - 09/2004
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 09/2004
2	Peptides (Polypeptides)IBA 07/2022 - 01/2006
2	HepcidinsIBA 03/2022 - 07/2021
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2012
2	caplacizumabIBA 01/2020 - 01/2020
2	Lipocalin-2IBA 01/2017 - 08/2011
2	AntibodiesIBA 09/2014 - 04/2013
1	empagliflozinIBA 09/2022
1	CanagliflozinIBA 09/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2022
1	VaccinesIBA 07/2022
1	OsteoprotegerinIBA 09/2021
1	Fibroblast Growth Factor-23IBA 01/2021
1	dirhodium tetraacetate (DRTA)IBA 06/2020
1	AcidsIBA 06/2020
1	EndostatinsIBA 01/2020
1	25-hydroxyvitamin DIBA 01/2019
1	MineralsIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	LaxativesIBA 08/2016
1	ElementsIBA 08/2016
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 10/2015
1	SaltsIBA 10/2015
1	Troleandomycin (TAO)FDA Link 09/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2014
1	EnzymesIBA 04/2013
1	Ligases (Synthetase)IBA 04/2013
1	Transfer RNA (tRNA)IBA 04/2013
1	Angiotensin IIIBA 06/2009
1	cyclic arginine-glycine-aspartic acid peptideIBA 01/2006
1	ApolipoproteinsIBA 01/2006
1	Apolipoproteins E (ApoE)IBA 01/2006
1	Integrin alpha4beta1 (VLA-4)IBA 01/2006
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2006
1	AntigensIBA 01/2006
1	Glutathione (Reduced Glutathione)IBA 09/2004
1	Blood Glucose (Blood Sugar)IBA 09/2004
1	ebselenIBA 09/2004
1	3-nitrotyrosineIBA 09/2004
1	7,8-dihydrobiopterinIBA 09/2004
1	LipidsIBA 09/2004
1	sapropterin (tetrahydrobiopterin)FDA Link 09/2004

Therapy/Procedure

1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021
1	Renal Dialysis (Hemodialysis) 01/2019
1	Ligation 01/2006
1	Therapeutics 09/2004